ID: ALA3220408

Max Phase: Preclinical

Molecular Formula: C17H16O3

Molecular Weight: 268.31

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC1(C)C=C(c2cccc(O)c2)c2ccc(O)cc2O1

Standard InChI:  InChI=1S/C17H16O3/c1-17(2)10-15(11-4-3-5-12(18)8-11)14-7-6-13(19)9-16(14)20-17/h3-10,18-19H,1-2H3

Standard InChI Key:  CSHQFGVHTLLLJB-UHFFFAOYSA-N

Associated Targets(non-human)

C3H 10T1/2 488 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 268.31Molecular Weight (Monoisotopic): 268.1099AlogP: 3.70#Rotatable Bonds: 1
Polar Surface Area: 49.69Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.07CX Basic pKa: CX LogP: 3.70CX LogD: 3.69
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.83Np Likeness Score: 1.33

References

1. Oh S, Cho SW, Yang J, Sun HJ, Chung YS, Shin CS, Park SB.  (2011)  Discovery of a novel benzopyranyl compound as a potent in vitro and in vivo osteogenic agent,  (1): [10.1039/C0MD00149J]

Source